1. Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment
   Julia Krushkal et al, 2016, Clinical Epigenetics CrossRef
2. A recently evolved class of alternative 3′-terminal exons involved in cell cycle regulation by topoisomerase inhibitors
   Martin Dutertre et al, 2014, Nature Communications CrossRef
3. Structural Basis for the Recognition of Non-methylated DNA by the CXXC Domain
   Ke Liu et al, 2020, Journal of Molecular Biology CrossRef
4. MBD1 protects replication fork stability by recruiting PARP1 and controlling transcription-replication conflicts
   Guihui Yu et al, 2024, Cancer Gene Therapy CrossRef
5. Biomarkers to assess the efficiency of treatment with platinum-based drugs: what can metallomics add?
   Thiago de O. Araujo et al, 2014, Metallomics CrossRef
6. Methyl-CpG-Binding Domain Proteins: Readers of the Epigenome
   Qian Du et al, 2015, Epigenomics CrossRef
7. Double‐strand DNA break repair: molecular mechanisms and therapeutic targets
   Jinpeng Tan et al, 2023, MedComm CrossRef
8. LSD1 sustains pancreatic cancer growth via maintaining HIF1α-dependent glycolytic process
   Yi Qin et al, 2014, Cancer Letters CrossRef
9. Adverse effects of chemoradiotherapy on invasion and metastasis of tumor cells
   Wei Xiong et al, 2020, Genes & Diseases CrossRef
10. NR2F2-AS1 accelerates cell proliferation through regulating miR-4429/MBD1 axis in cervical cancer
    Dan Liu et al, 2020, Bioscience Reports CrossRef
11. DNA Modification Readers and Writers and Their Interplay
    Cathia Rausch et al, 2020, Journal of Molecular Biology CrossRef
12. MBD1 promotes the malignant behavior of gallbladder cancer cells and induces chemotherapeutic resistance to gemcitabine
    Liu Wensheng et al, 2019, Cancer Cell International CrossRef
13. Constitutional mismatch repair-deficiency: current problems and emerging therapeutic strategies
    Malak Abedalthagafi, 2018, Oncotarget CrossRef
14. The Expression of MBD6 Is Associated with Tumor Size in Uterine Leiomyomas
    Mei-Rong Liang et al, 2019, Genetic Testing and Molecular Biomarkers CrossRef
15. 5-Hydroxymethylcytosine: a Potential Therapeutic Target in Cancer
    Euan J Rodger et al, 2014, Epigenomics CrossRef
16. DNA damage, metabolism, and epigenetic regulation
    Shinjini Ganguly et al, 2022, Epigenetics and DNA Damage CrossRef
17. Comprehensive identification of proteins binding to RNA G-quadruplex motifs in the 5′ UTR of tumor-associated mRNAs
    Tatsuo Serikawa et al, 2018, Biochimie CrossRef
18. The Transcription Factor Cux1 in Cerebellar Granule Cell Development and Medulloblastoma Pathogenesis
    Sabine Topka et al, 2014, The Cerebellum CrossRef
19. An Epigenetic Regulator: Methyl-CpG-Binding Domain Protein 1 (MBD1)
    Lu Li et al, 2015, International Journal of Molecular Sciences CrossRef
20. Inactivation of Epigenetic Regulators due to Mutations in Solid Tumors
    M. V. Nemtsova et al, 2020, Biochemistry (Moscow) CrossRef
21. DNA Methylation and Adult Neurogenesis
    Emily M. Jobe et al, 2017, Brain Plasticity CrossRef
22. Zinc finger E-box-binding homeobox 1 mediates aerobic glycolysisviasuppression of sirtuin 3 in pancreatic cancer
    Wen-Yan Xu et al, 2018, World Journal of Gastroenterology CrossRef
23. DNA damage response signaling pathways and targets for radiotherapy sensitization in cancer
    Rui-Xue Huang et al, 2020, Signal Transduction and Targeted Therapy CrossRef
24. LyP‐1‐fMWNTs enhanced targeted delivery of MBD1siRNA to pancreatic cancer cells
    Quan‐Jun Lin et al, 2020, Journal of Cellular and Molecular Medicine CrossRef